essive glomerular disease.Kidney Int，1986，29(2):502-510.
3Wheeler DC.Lipid abnormalities in the nephritic syndrome:the therapeutic role of statins.J Nephrol，2001，14(Suppl 4):S70-S75.
4Ikejiri A,Hirano T,Murayama S,et al.Effects of atorvastatin on triglyceride-rich lipoproteins,low-density lipoproteinsubclass,and C-reactive protein in hemodialysis.Metabolism，2004，53(9)：1113-1117.
5Nosadini R,Clipollina MR,Solini A,et al.Close relationship between microalbuminuria and insulin resistance in essential hypertension and non-insulin dependent diabetes mellitus.J Am Soc Nephrol，1992，(Suppl 3):S56-S63.
6Samuelsson O,Mulec H,Knight-Gibson C,et al.Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.Nephrol Dial Transplant，1997，12(9):1908-1915.
7Tang WW,Feng L,Loskutoff DF,et al.Glomerular extracellular matrix accumulation in experimental anti-GBM Ab glomerulonephritis.Nephron，2000，84(1):40-48.
8Kim TS,Kim JY,Hong HK,et al.mRNA expression of glomerular basement membrane proteins and TGF-beta1 in human membranuous nephropathy.J Pathol，1999，189(3):425-430.
9Joles JA,Kunter UTA,Janssen ULF,et al.Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats.J Am Soc Nephrol，2000，11(4):669-683.
上一页 [1] [2] [3] [4] [5]
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文